Dyne Therapeutics, Inc. (DYN)
Market Open
26 Oct, 07:34 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
15. 66
+0.04
+0.2881%
$
2.66B Market Cap
- P/E Ratio
- Div Yield
109,481 Volume
-3.29 Eps
$ 15.62
Previous Close 
Want to track DYN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.14 | - |
| | | 0.21 | - |
| | | - | - |
DYN Earnings Reports FAQ
What is the earnings per share (EPS) for DYN?
The current EPS is -3.29.
What is the company's earnings growth rate?
Dyne Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Dyne Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Dyne Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for DYN at this time, as Dyne Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
